Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SterlingBio is a private healthcare technology and clinical development services company focused on cloud-native eClinical applications and related services for life sciences organizations. The company appears to provide software and managed services spanning ETMF, CTMS, investigator site file, quality management, e-signature/compliance workflows, and clinical analytics/AI. Its offerings are aimed at biopharma, medical device, and regulated healthcare users seeking to streamline clinical trial operations, documentation, and collaboration. Available public information indicates SterlingBio operates more as a digital clinical operations and services provider than as a therapeutic drug developer, so it does not appear to maintain a conventional drug pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SterlingBio.